Imugene LtdImugene LtdImugene Ltd

Imugene Ltd

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪79.87 M‬AUD
−0.315AUD
‪−69.02 M‬AUD
0.00AUD
‪255.95 M‬
Beta (1Y)
1.39
Employees (FY)
23
Revenue / Employee (1Y)
0.00AUD
Net income / Employee (1Y)
‪−3.00 M‬AUD

About Imugene Ltd


CEO
Leslie Chong
Headquarters
Sydney
Founded
1986
ISIN
AU000000IMU9
FIGI
BBG000BZ3TD8
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.

Check out other big names from the same industry as IMU.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IMU is 0.270 AUD — it has increased by 3.70% in the past 24 hours. Watch Imugene Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Imugene Ltd stocks are traded under the ticker IMU.
IMU stock has fallen by −6.67% compared to the previous week, the month change is a 3.70% rise, over the last year Imugene Ltd has showed a −85.02% decrease.
IMU reached its all-time high on Jun 30, 1994 with the price of 250.215 AUD, and its all-time low was 0.135 AUD and was reached on Jun 17, 2013. View more price dynamics on IMU chart.
See other stocks reaching their highest and lowest prices.
IMU stock is 5.56% volatile and has beta coefficient of 1.39. Track Imugene Ltd stock price on the chart and check out the list of the most volatile stocks — is Imugene Ltd there?
Today Imugene Ltd has the market capitalization of ‪77.89 M‬, it has increased by 7.55% over the last week.
Yes, you can track Imugene Ltd financials in yearly and quarterly reports right on TradingView.
Imugene Ltd is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
IMU net income for the last half-year is ‪−20.68 M‬ AUD, while the previous report showed ‪−48.34 M‬ AUD of net income which accounts for 57.21% change. Track more Imugene Ltd financial stats to get the full picture.
No, IMU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2025, the company has 23 employees. See our rating of the largest employees — is Imugene Ltd on this list?
Like other stocks, IMU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Imugene Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Imugene Ltd technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Imugene Ltd stock shows the sell signal. See more of Imugene Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.